Patents Assigned to Max-Planck-Gessellschaft zur Foerderung der Wissenschaften e.V.
  • Patent number: 8992783
    Abstract: Method for enantioseparation of a chiral system with compound formation comprising a pair of enantiomers. The method comprises the steps of: placing the chiral system to be processed, which is optically enriched by a target enantiomer, in the 3-phase region of the ternary phase diagram of chiral compound forming systems to achieve the establishment of the solid/liquid phase equilibria; phase-separating the liquid and solid phase formed by the placing step; shifting the eutectic composition of the remaining liquid towards a lower eutectic composition (xE) until the overall composition is located in the 2-phase region of the ternary phase diagram of chiral compound forming systems; and performing crystallization in the 2-phase region of the ternary phase diagram for obtaining the target enantiomer in the solid phase. In some cases the shifting step can be skipped.
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: March 31, 2015
    Assignee: Max-Planck-Gessellschaft zur Förderung der Wissenschaften e.V.
    Inventors: Heike Lorenz, Henning Kaemmerer, Daniel Polenske, Andreas Seidel-Morgenstern
  • Publication number: 20100065810
    Abstract: A method of synthesizing semiconductor nanostructures of at least one semiconductor material (e.g. nanowires, nanorods, nanoribbons, nanodots, quantumdots, etc.) is described which includes the steps of placing a solid catalyst particle on a substrate, placing the combination of the said substrate and the said solid catalyst in a chamber of low oxygen partial pressure, below I×10?2 mbar, adding one or more gaseous reactants comprising at least one of said semiconductor material and a suitable precursor therefor and heating the said combination to a temperature above 200° C. but below the melting point of the solid catalyst particle. Nanostructures made by the method are also claimed.
    Type: Application
    Filed: April 5, 2007
    Publication date: March 18, 2010
    Applicant: Max-Planck-Gessellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Ulrich Goesele, Stephan Senz, Volker Schmidt, Yewu Wang
  • Patent number: 6613331
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: September 2, 2003
    Assignees: Max-Planck-Gessellschaft zur förderung der Wissenschaften e.V., Deutsches Krebsforschun zentrum Stiftung des öffentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard